Nauzene is a Oral Syrup in the Human Otc Drug category. It is labeled and distributed by Alva-amco Pharmacal Companies, Inc.. The primary component is Trisodium Citrate Dihydrate; Dextrose; Fructose.
Product ID | 52389-172_b35b5e0f-9b2e-40ae-9db7-65f245e40844 |
NDC | 52389-172 |
Product Type | Human Otc Drug |
Proprietary Name | Nauzene |
Generic Name | Sodium Citrate |
Dosage Form | Syrup |
Route of Administration | ORAL |
Marketing Start Date | 2000-02-15 |
Marketing Category | OTC MONOGRAPH NOT FINAL / OTC MONOGRAPH NOT FINAL |
Application Number | part357 |
Labeler Name | Alva-Amco Pharmacal Companies, Inc. |
Substance Name | TRISODIUM CITRATE DIHYDRATE; DEXTROSE; FRUCTOSE |
Active Ingredient Strength | 1 g/15mL; g/15mL; g/15mL |
NDC Exclude Flag | E |
Listing Certified Through | 2018-12-31 |
Marketing Start Date | 2000-02-15 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | OTC monograph not final |
Application Number | part357 |
Product Type | HUMAN OTC DRUG |
Marketing Start Date | 2000-02-15 |
Inactivation Date | 2020-01-31 |
Ingredient | Strength |
---|---|
TRISODIUM CITRATE DIHYDRATE | .921 g/15mL |
SPL SET ID: | 728376f5-6cab-404e-b519-f6c595291d6f |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
UPC Code |
NDC | Brand Name | Generic Name |
---|---|---|
52389-172 | Nauzene | Sodium Citrate |
52389-242 | Nauzene | Sodium Citrate |
62646-798 | Anticoagulant Sodium Citrate | Sodium Citrate |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
NAUZENE 74469794 1909137 Live/Registered |
ALVA-AMCO PHARMACAL COS., INC. 1993-12-16 |